Enoxaparin Sodium Prices June 2023
Product
|
Category |
Region |
Price |
Enoxaparin Sodium |
Pharma API |
China |
24,000 USD/Kg |
The price of enoxaparin sodium in China for Q2 2023 reached 24,000 USD/Kg in June.
Enoxaparin Sodium Price Trend, Market Analysis, and News
IMARC’s newly published report, titled “Enoxaparin Sodium Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of enoxaparin sodium pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.
It encompasses an in-depth review of spot price of enoxaparin sodium at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of enoxaparin sodium price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.
The report examines the elements influencing enoxaparin sodium price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.
Enoxaparin Sodium Market Analysis
The global enoxaparin sodium market size reached US$ 3.8 Billion in 2023. By 2032, IMARC Group expects the market to reach US$ 9.2 Billion, at a projected CAGR of 10.30% during 2023-2032.
- In surgical settings, enoxaparin sodium is extensively used as a prophylactic agent to prevent postoperative thromboembolic complications. The chances of venous thromboembolism (VTE) occurring in major orthopedic surgeries, such as hip or knee replacement, are very high. Enoxaparin sodium massively decreases this occurrence. It is also used for abdominal surgery among patients who are suffering from malignancies and those undergoing general surgeries who are at risk of thromboembolism. By preventing the blood from forming clots, it minimizes the risk of any complications that may be life-threatening after surgery. Further, the increased geriatric populations worldwide are increasing the scope for successful orthopedic surgery. As per the India Ageing Report 2023 by the United Nations Population Fund, by 2046, the old population of India will outnumber the population of children between the ages of 0 and 15 years.
- Moreover, enoxaparin sodium plays a significant role in the management of acute coronary syndromes (ACS), including unstable angina and non-ST-segment elevation myocardial infarction (NSTEMI). It helps stabilize the patient by reducing the risk of further thrombus formation and subsequent cardiac events. In conjunction with other therapies, such as antiplatelet agents, enoxaparin sodium is part of the standard treatment protocol to improve patient outcomes in these critical conditions.
- Enoxaparin sodium is very useful in cases of VTE in pregnancy. Physiological changes during pregnancy make the chances of a thromboembolic event higher for a pregnant woman. Enoxaparin sodium is usually preferred because it does not cross over the placenta, hence safer for the fetus compared to other anticoagulants, such as warfarin. It is used both for the prophylaxis and treatment of VTE in pregnant women, ensuring that the mother is healthy without risking the safety of the fetus. Pregnant women who face complications are more likely to have complications in subsequent pregnancies, as stated in Pregnancy Statistics (2024) from Forbes Health. This is raising awareness and promoting the use of effective medications such as enoxaparin sodium by healthcare providers.
- Cancer patients are at an increased risk of VTE because of a hypercoagulable state related to malignancy itself and its therapy. Enoxaparin sodium is counted in the list of most frequently used agents for primary and secondary thromboprophylaxis of VTE in the population.
Enoxaparin Sodium News
The report covers the latest developments, updates, and trends impacting the global enoxaparin sodium market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in enoxaparin sodium production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the enoxaparin sodium price trend.
Latest developments in the enoxaparin sodium industry:
- In 2023: Techdow USA announced the launch of its 30mg, 40mg, 60mg, 80mg, 100mg, 120mg, and 150mg strengths of generic Lovenox (Enoxaparin Sodium- preservative free).
- In 2023: Meitheal Pharmaceuticals, Inc. declared that it will start distributing the enoxaparin sodium injection, USP pre-filled syringes with certain changes.
Product Description
Enoxaparin Sodium is a low molecular weight heparin (LMWH) derived from unfractionated heparin. It functions primarily as an anticoagulant, preventing the formation of blood clots. It has a higher bioavailability and a longer half-life, permitting once or twice-daily dosing. It is essential in the prevention and management of thromboembolic disorders, which are associated with significant morbidity and mortality. It significantly reduces the incidence of deep vein thrombosis (DVT) and pulmonary embolism (PE) in postoperative patients, thus improving surgical outcomes. It enhances patient adherence and convenience, especially in outpatient settings where prolonged anticoagulation therapy might be required. It is used to prevent clotting in the dialysis circuit. It ensures the smooth operation of dialysis sessions and reduces the risk of clot-related complications. In pregnancy, Enoxaparin offers a safe and effective option for preventing and treating VTE. Its ability to prevent clot formation without crossing the placenta ensures that both maternal and fetal health are safeguarded.
Regional Coverage
The report provides a detailed analysis of the enoxaparin sodium market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the enoxaparin sodium price trend.
Global Enoxaparin Sodium Price
The report offers a holistic view of the global enoxaparin sodium pricing trends in the form of enoxaparin sodium price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of enoxaparin sodium but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.
The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed enoxaparin sodium demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.
Europe Enoxaparin Sodium Price
European enoxaparin sodium prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.
This analysis can be extended to include detailed enoxaparin sodium price information for a comprehensive list of countries.
Region |
Countries Covered |
Europe |
Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Enoxaparin Sodium Price
The analysis of enoxaparin sodium prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.
Specific enoxaparin sodium historical data within the United States and Canada can also be provided.
Region |
Countries Covered |
North America |
United States and Canada |
Middle East and Africa Enoxaparin Sodium Price
The report explores the enoxaparin sodium pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on enoxaparin sodium prices for countries can also be provided.
Region |
Countries Covered |
Middle East & Africa |
Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Enoxaparin Sodium Price
The enoxaparin sodium pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.
This enoxaparin sodium price analysis can be expanded to include a comprehensive list of countries within the region.
Region |
Countries Covered |
Asia Pacific |
China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Enoxaparin Sodium Price
The analysis of enoxaparin sodium prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.
This comprehensive review can be extended to include specific countries within the region.
Region |
Countries Covered |
Latin America |
Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Report Coverage
Key Attributes |
Details |
Product Name |
Enoxaparin Sodium |
Report Features |
Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Enoxaparin Sodium Price Analysis, and Segment-Wise Assessment. |
Currency/Units |
US$ (Data can also be provided in local currency) or Metric Tons |
Region/Countries Covered |
The current coverage includes analysis at the global and regional levels only.
Based on your requirements, we can also customize the report and provide specific information for the following countries:
Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece*
North America: United States and Canada
Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru*
Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco*
*The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
Information Covered for Key Suppliers |
- Company Overview
- Business Description
- Product Portfolio
- Recent Trends and Developments
|
Customization Scope |
The report can be customized as per the requirements of the customer |
Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
- Scope
- Historical Data for the Current Month
- Forecast for Next Month
- Total Deliverables Per Year: 12 (One Per Month)
- Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year
Plan B: Quarterly Updates - Annual Subscription
- Scope
- Historical Data for the Current Quarter
- Forecast for Next Quarter
- Total Deliverables Per Year: 4 (One Per Quarter)
- Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year
Plan C: Biannually Updates - Annual Subscription
- Scope
- Historical Data for the Current Half
- Forecast for the Next Half
- Total Deliverables Per Year: 2 (One Per 6 Months)
- Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year
|
Post-Sale Analyst Support |
360-degree analyst support after report delivery |
Delivery Format |
PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of enoxaparin sodium pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting enoxaparin sodium price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The enoxaparin sodium price charts ensure our clients remain at the forefront of the industry.